GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanosonics Ltd (ASX:NAN) » Definitions » Institutional Ownership

Nanosonics (ASX:NAN) Institutional Ownership : 25.74% (As of Jun. 09, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Nanosonics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Nanosonics's institutional ownership is 25.74%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Nanosonics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Nanosonics's Float Percentage Of Total Shares Outstanding is 0.00%.


Nanosonics Institutional Ownership Historical Data

The historical data trend for Nanosonics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosonics Institutional Ownership Chart

Nanosonics Historical Data

The historical data trend for Nanosonics can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 23.94 25.75 25.75 25.75 26.08 25.72 25.60 25.87 25.73 25.74

Nanosonics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Nanosonics (ASX:NAN) Business Description

Traded in Other Exchanges
Address
7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113
Nanosonics is a single-product firm and its trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low temperature sonically activated hydrogen peroxide mist that is suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection across patients. Nanosonics' revenue is made up of capital sales of trophon units, ongoing consumables sales, and service revenue. At June 2022, there were 29,850 trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, roughly 44% in the U.S. to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in Asia-Pacific.

Nanosonics (ASX:NAN) Headlines